Certified by Founder Lodge
SURGE Therapeutics
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $32,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
SURGE seeks to dramatically improve cancer patient survival by disrupting how, when, and where cancer immunotherapy is deployed -- focusing 100% of the effective dose at the right place and a
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 20 ,2023 | Series B | $32,000,000 |
Alumni Ventures
Khosla Ventures
Intuitive Ventures
8VC
KdT Ventures
Pitango
Camford Capital
Piedmont Capital
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
OTPLESS | $3,500,000 | (May 17, 2024)
Watershed Health | $13,600,000 | (May 17, 2024)
Aeropay | $20,000,000 | (May 17, 2024)
c/side | $1,700,000 | (May 17, 2024)
SINE Digital | $2,500,000 | (May 17, 2024)
